TCMD

Tactile Systems Technology Inc

Add to Watchlist

Advanced Chart

10.550

+0.3(2.927%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

10.670

Open

10.280

VWAP

10.45

Vol

204.76K

Mkt Cap

245.27M

Low

10.090

Amount

2.14M

EV/EBITDA(TTM)

6.27

Total Shares

23.76M

172.24M

EV/OCF(TTM)

4.29

P/S(TTM)

0.87

Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company that manufactures and distributes medical devices for the treatment of patients with chronic diseases at home. The Company's areas of therapeutic focus are vascular disease, oncology and providing airway clearance therapy for those suffering from chronic respiratory conditions. It is developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. It markets Flexitouch Plus and Entre Plus systems as at-home therapies for the treatment of lymphedema and chronic venous insufficiency. It markets AffloVest as an at-home therapy intended to promote airway clearance. Its Flexitouch Plus system is a fully automated, programmable, advanced pneumatic compression device. It also offers Kylee, a free mobile application that helps patients learn about lymphedema.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2025Q3

FY2025Q2

94.38M

+10.27%

0.375

-6.53%

80.50M

+10.14%

0.180

-26.86%

73.93M

+0.98%

0.145

-26.51%

Estimates Revision

The market is revising Downward the revenue expectations for Tactile Systems Technology, Inc. (TCMD) for FY2025, with the revenue forecasts being adjusted by -1.99% over the past three months. During the same period, the stock price has changed by -25.55%.

Revenue Estimates for FY2025

Revise Downward

-1.99%

In Past 3 Month

EPS Estimates for FY2025

Revise Downward

-8.06%

In Past 3 Month

Stock Price

Go Down

-25.55%

In Past 3 Month

4 Analyst Rating

23.22% Upside

Wall Street analysts forecast TCMD stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for TCMD is 13.00 USD with a low forecast of 12.00 USD and a high forecast of 14.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

3 Hold

0 Sell

Hold

23.22% Upside

Current: 10.550

Low

12.00

Averages

13.00

High

14.00

23.22% Upside

Current: 10.550

Low

12.00

Averages

13.00

High

14.00

B. Riley Securities

Kyle Bauser

Strong Buy

Hold

Downgrades

$23 → $18

2025-02-19

Reason

B. Riley Securities

Kyle Bauser

Price Target

$23 → $18

2025-02-19

Downgrades

Strong Buy

Hold

Reason

BTIG

Sean Lavin

Strong Buy

Hold

Downgrades

n/a

2024-11-05

Reason

BTIG

Sean Lavin

Price Target

n/a

2024-11-05

Downgrades

Strong Buy

Hold

Reason

See All Ratings

Valuation Metrics

The current forward P/E ratio for Tactile Systems Technology Inc (TCMD.O) is 16.36, compared to its 5-year average forward P/E of 111.67. For a more detailed relative valuation and DCF analysis to assess Tactile Systems Technology Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

111.67

Current PE

16.36

Overvalued PE

604.62

Undervalued PE

-381.28

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Fair

5Y Average EV/EBITDA

19.38

Current EV/EBITDA

5.85

Overvalued EV/EBITDA

34.85

Undervalued EV/EBITDA

3.92

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair

5Y Average PS

1.88

Current PS

0.75

Overvalued PS

3.23

Undervalued PS

0.54